Patent analysis for obeticholic acid
WANG Xing
ZHU Fang
Abstract:Obeticholic acid,a chenodeoxycholic acid derivative among human primary bile acids,acts as an agonist for the farnesoid X receptor.This article introduces a process for the preparation of obeticholic acid and discusses the status of related patent applications concerning its crystalline form.By combining the context of the key patent technology and summarizing related aspects of technology evolution and efficacy relationships,this article aims to provide beneficial references for fair patent placement,patent mining,prevention of patent infringement for imitation businesses,as well as the guidance on technological development and the strategic intellectual property considerations for domestic pharmaceutical businesses.
Keywords:obeticholic acidchenodeoxycholic acidfarnesoid X receptor agonistspatent analysis
Publication Date:2025-09-15
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:6( 1802-1807 )
Chinese Journal of New Drugs

Chinese Journal of New Drugs

ISTICPKUCSCD
ISSN:1003-3734
Year, Vol.(Issue):2025,34(17)